Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma

Purpose Diffuse large B‐cell lymphoma (DLBCL), the most common non‐Hodgkin lymphoma, is a heterogeneous lymphoma with different clinical manifestations and molecular alterations, and several markers are currently being measured routinely for its diagnosis, subtyping, or prognostication by immunohist...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Proteomics. Clinical applications 2020-01, Vol.14 (1), p.e1900091-n/a
Hauptverfasser:	Suzuki, Masaki, Muroi, Atsushi, Nojima, Masanori, Numata, Ayumi, Takasaki, Hirotaka, Sakai, Rika, Yokose, Tomoyuki, Miyagi, Yohei, Koshikawa, Naohiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antigens, CD20 - genetics Arrays Bcl-6 protein Biomarkers Biomarkers, Tumor - genetics CD20 antigen CD5 antigen CD5 Antigens - genetics Correlation C‐MYC Design of experiments Diagnosis diffuse large B‐cell lymphoma (DLBCL) Experimental design Female Gene Expression Regulation, Neoplastic - genetics Humans Immunohistochemistry immunohistochemistry (IHC) Immunohistochemistry - methods Interferon Regulatory Factors - genetics Ki-67 Antigen - genetics Lymphoma lymphoma prognosis Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - genetics Lymphoma, Large B-Cell, Diffuse - pathology Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - genetics Lymphoma, Non-Hodgkin - pathology Male Middle Aged Myc protein Non-Hodgkin's lymphoma PAX5 Transcription Factor - genetics Prognosis Protein Array Analysis - methods Protein arrays Proteins Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-myc - genetics reverse‐phase‐protein‐array (RPPA)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!